Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Healthcare professionals should assess individual psychiatric history before prescribing and maintain regular monitoring throughout treatment
Phase 2 trial results The Phase 2 trial established the dose-response pattern that researchers have been tracking ever since
For example, high-fat feeding alters the small intestinal microbiota to increase intestinal, brain, and circulatory levels of taurine-conjugated bile acids, including and taurochenodeoxycholic acid (TCDCA), which is an FXR agonist 272
Additionally, liver volume decreased significantly, and improvements were observed in biomarkers of hepatic injury and inflammation, suggesting potential antifibrotic and anti-inflammatory properties in these models
